Pop Mood Daily
general /

BBIO BridgeBio Pharma Inc Compare

insidermonkey

12 Most Promising Stocks to Buy According to Hedge Funds

fool

Why BridgeBio Pharma Was a Healthy Stock Today

investors

Pfizer Was First In Treating This Heart Disease. Why BridgeBio Could Be Better.

insidermonkey

15 Best Performing Stocks in the Last 6 Months

gurufocus

Andreas Halvorsen's Q2 2023 13F Filing Update

investors

BridgeBio Launches 64% Higher, Pulling Alnylam And Ionis With It, On A 'Best-Case' In Heart Disease

fool

2 Growth Stocks With Major Incoming Catalysts

yahoo

Rare Disease Player BridgeBio Pharma Draws Attention Of Big Pharma Companies, Gets Takeover Interest

fool

These 2 Biotech Stocks Made Big Monday Moves

benzinga

BridgeBio's Dwarfism Candidate Shows Favorable Height Increase, Safety Profile

fool

Why BridgeBio Pharma Stock Is Skyrocketing Today

barrons

BridgeBio Stock Surges on Positive Dwarfism Drug Data. It’s Bad News for BioMarin.

investors

BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study

yahoo

BridgeBio Pharma Highlights its RAS Precision Oncology Portfolio and Shares Compelling Data from Next-generation G12C Inhibitor and Novel PI3Kα:RAS Breaker Mechanism at the Fourth RAS Initiative Symposium - Yahoo Finance

yahoo

BridgeBio Pharma Presents 12-month Results from Phase 2 Study of BBP-418 in Limb-Girdle Muscular Dystrophy Type 2i - Yahoo Finance

yahoo

BridgeBio Pharma Announces First Lung Cancer Patient Dosed in Phase 1/2 Trial and US FDA Fast Track Designation for SHP2 inhibitor BBP-398 in Combination with Amgen’s LUMAKRAS® - Yahoo Finance

yahoo

BridgeBio Pharma Affiliate Phoenix Tissue Repair Announces Positive Results from Phase 2 Trial of PTR-01, a Protein Replacement Therapy for the Treatment of Recessive Dystrophic Epidermolysis Bullosa - Yahoo Finance

fool

10 Amazing Stocks Under $10

yahoo

BridgeBio Pharma Presents Updated Results from Phase 2 Open-label Extension Study of Acoramidis in Transthyretin Amyloid Cardiomyopathy - Yahoo Finance

fool

3 Can't-Miss Biotech Events Coming Up in 2022